Mary Philip, M.D., Ph.D. is an Assistant Professor of Medicine, Division of Hematology/Oncology and an Assistant Professor of Pathology, Microbiology and Immunology. She grew up in Chicago and received her BS in Molecular Biophysics and Biochemistry from Yale University and her M.D. and Ph.D. in cancer biology from the University of Chicago. She completed her residency at the University of Chicago and her Hematology/Oncology Fellowship training at the Fred Hutchinson Cancer Research Center/University of Washington in Seattle. She then worked at Memorial Sloan Kettering Cancer Center in New York to decipher the epigenetic regulation of tumor-specific T cell dysfunction before moving to Nashville... Click Dr. Philip's photo to continue reading.

Dietary Intake Regulates the Circulation Inflammatory monocyte Pool. Jordan S, et al. in Cell, August 22, 2019 Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Duan Y, et al.

Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus. Kim S, et al. in Nature, August 21, 2019 Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis. Dai J, et al.

Young Kim, M.D., Ph.D., Professor of Otolaryngology and co-leader of the Translational Research and Interventional Oncology Research Program, is a clinician-scientist focused on the development of immunotherapeutic modalities for solid tumors... Click on Dr. Kim's photo to continue reading.

Long-Distance Cooperative and Antagonistic RNA Polymerase Dynamics via DNA Supercoiling. Sangjin Kim, et al. in Cell Press, September 19, 2019 TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors. Guerin M, et al.

Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory. Blelloch R, Poggio M, et al. in Cell Reports, April 4, 2019 Viral complementation of immunodeficiency confers protection against enteric pathogens via interferon-λ. Baldridge MT, Ingle H, et al.

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. Voorwerk L, et al in Nature, May 13, 2019 Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit.

Plants send small RNAs in extracellular vesicles to fungal pathogen to silence virulence genes.